ICD-10-CM Billable Code

H16.402

Unspecified corneal neovascularization, left eye

Clinical Classification Guidelines

Medical Intelligence & Overview

Corneal neovascularization in the left eye refers to the abnormal growth of blood vessels into the cornea—the clear, dome-shaped surface that covers the front of the eye. When this condition is classified as unspecified (ICD-10 code H16.402), it indicates that detailed information about the specific cause or type of neovascularization has not been documented. This condition can affect vision and eye health, making awareness and understanding essential for those affected.

Causes & Symptoms

Clinical Causes: Chronic hypoxia (lack of oxygen to the cornea), often due to contact lens overuse or poor oxygen permeability Corneal infections, such as bacterial, viral, or fungal infections Inflammatory eye conditions, including uveitis or keratitis Trauma or injury to the eye, leading to compromised corneal health Previous eye surgeries or procedures that disturb corneal integrity Autoimmune conditions that affect the eye Exposure to environmental irritants or pollutants

Key Symptoms: Decreased or blurred vision Redness and inflammation of the eye Tearing or watery eyes Sensations of foreign body or irritation Light sensitivity (photophobia) Discomfort or mild pain in the eye Appearance of blood vessels growing into the corneal area

Diagnostic & Treatment

Diagnosis Path: Diagnosis typically involves a comprehensive eye examination by an eye care professional. The examination includes slit-lamp biomicroscopy to visualize the corneal surface and detect abnormal blood vessel growth. Additional tests may include corneal staining and imaging techniques like anterior segment optical coherence tomography (OCT) to assess the extent of neovascularization and underlying corneal health. Identifying the cause behind the neovascularization is important for guiding effective management.

Treatment Protocols: Management of corneal neovascularization focuses on stopping the abnormal vessel growth and preserving or restoring vision. Treatment options may include: - **Medication:** Use of corticosteroid eye drops to reduce inflammation; anti-vascular endothelial growth factor (anti-VEGF) agents may sometimes be administered to inhibit new blood vessel growth. - **Laser therapy:** Laser treatments such as argon laser photocoagulation can be employed to target and destroy abnormal vessels. - **Surgical procedures:** In severe cases, procedures like corneal transplantation may be necessary if the neovascularization causes significant damage or vision loss. - **Addressing underlying causes:** Managing contributing factors like infections, inflammation, or hypoxia is crucial to prevent recurrence. Regular follow-up with an eye specialist is essential to monitor the condition and adjust treatment as needed.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is H16.402 a billable ICD-10 code?
Yes, H16.402 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report H16.402?
Clinical documentation must specify the nature of Unspecified corneal neovascularization, left eye and any associated comorbidities for accurate reporting.

Cite this Clinical Reference